Endoscopy, the standard for detecting esophageal precancer, is quite an invasive procedure — so a lot of people who should be screened end up never being tested. Lucid Diagnostics is trying to solve this problem by selling a quick, office-based diagnostic.
The agency gave an emergency use authorization to the testing assay, developed by Rutgers University, Spectrum Solutions and Accurate Diagnostic Labs, for collection of samples at home. The saliva-based test was originally authorized last month.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!